Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.

[This corrects the article DOI: 10.1371/journal.pone.0245827.].

Bibliographic Details
Main Authors:	Atul T Patel, Mark F Lew, Khashayar Dashtipour, Stuart Isaacson, Robert A Hauser, William Ondo, Pascal Maisonobe, Stefan Wietek, Bruce Rubin, Allison Brashear
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0250475

id	doaj-678fa54813e44fa6aee14de2d0af6f97
record_format	Article
spelling	doaj-678fa54813e44fa6aee14de2d0af6f972021-07-18T04:30:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01164e025047510.1371/journal.pone.0250475Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.Atul T PatelMark F LewKhashayar DashtipourStuart IsaacsonRobert A HauserWilliam OndoPascal MaisonobeStefan WietekBruce RubinAllison Brashear[This corrects the article DOI: 10.1371/journal.pone.0245827.].https://doi.org/10.1371/journal.pone.0250475
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Atul T Patel Mark F Lew Khashayar Dashtipour Stuart Isaacson Robert A Hauser William Ondo Pascal Maisonobe Stefan Wietek Bruce Rubin Allison Brashear
spellingShingle	Atul T Patel Mark F Lew Khashayar Dashtipour Stuart Isaacson Robert A Hauser William Ondo Pascal Maisonobe Stefan Wietek Bruce Rubin Allison Brashear Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study. PLoS ONE
author_facet	Atul T Patel Mark F Lew Khashayar Dashtipour Stuart Isaacson Robert A Hauser William Ondo Pascal Maisonobe Stefan Wietek Bruce Rubin Allison Brashear
author_sort	Atul T Patel
title	Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
title_short	Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
title_full	Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
title_fullStr	Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
title_full_unstemmed	Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
title_sort	correction: sustained functional benefits after a single set of injections with abobotulinumtoxina using a 2-ml injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
publisher	Public Library of Science (PLoS)
series	PLoS ONE
issn	1932-6203
publishDate	2021-01-01
description	[This corrects the article DOI: 10.1371/journal.pone.0245827.].
url	https://doi.org/10.1371/journal.pone.0250475
work_keys_str_mv	AT atultpatel correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT markflew correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT khashayardashtipour correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT stuartisaacson correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT robertahauser correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT williamondo correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT pascalmaisonobe correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT stefanwietek correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT brucerubin correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT allisonbrashear correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy
_version_	1721296563024691200

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.

Similar Items